Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Hologic receives CE Mark approval for MyoSure Manual device

Hologic receives CE Mark approval for MyoSure Manual device

4th January 2018

Hologic has been granted European regulatory approval for MyoSure Manual, a new device offering simplified intrauterine tissue removal capabilities.

The product is part of the broader MyoSure suite of gynaecological surgery products, which facilitate minimally invasive hysteroscopic treatment for women with problematic tissue that requires no cauterisation, meaning uterine form and function can be preserved.

MyoSure Manual aids this by providing a fully integrated vacuum, with no external suction required. It uses the support of a one-litre saline bag, and does not utilise a controller or any additional fluid management capital equipment.

The clear tissue trap allows visual confirmation of tissue removal, and can also be detached to send straight to pathology. In addition, MyoSure Manual provides physicians with multi-functional control of the 360-degree blade.

Jan Verstreken, Hologic's president in Europe and Canada, said: "The MyoSure Manual device is an exciting addition to our growing portfolio of gynaecologic solutions in Europe, all of which have been developed with the patient and physician in mind."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.